Showing results (161-170 of 1,603) with videos related to

Sort By:
Pageof 161
American Heart Journal|April 30, 2017
Trends in health care expenditure among US adults with heart failure: The Medical Expenditure Panel Survey 2002-2011Justin B Echouffo-Tcheugui, Kinfe G Bishu, Gregg C Fonarow, et al.
Journal of the American College of Cardiology|March 25, 2014
Therapeutic targets in heart failure: refocusing on the myocardial interstitiumErik B Schelbert, Gregg C Fonarow, Robert O Bonow, et al.
American Heart Journal Plus : Cardiology Research and Practice|April 1, 2024
Guideline-directed device therapies in heart failure: A clinical practice-based analysis using electronic health record dataAnne B Curtis, Christopher Manrodt, Luke D Jacobsen, et al.
JAMA Cardiology|October 2, 2024
Global Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart FailureAmber B Tang, Boback Ziaeian, Javed Butler, et al.
JACC. Heart Failure|November 12, 2018
Initiation, Continuation, Switching, and Withdrawal of Heart Failure Medical Therapies During HospitalizationAditi A Bhagat, Stephen J Greene, Muthiah Vaduganathan, et al.
The American Journal of Cardiology|September 9, 2008
Weekend/holiday versus weekday hospital discharge and guideline adherence (from the American Heart Association's Get with the Guidelines--Coronary Artery Disease database)Sumit Tickoo, Gregg C Fonarow, Adrian F Hernandez, et al.
BMC Medicine|March 29, 2022
Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetesArnaud D Kaze, Bernard G Jaar, Gregg C Fonarow, et al.
The American Journal of Cardiology|July 2, 2008
Cachexia: common, deadly, with an urgent need for precise definition and new therapiesMitja Lainscak, Gerasimos S Filippatos, Mihai Gheorghiade, et al.
Heart Failure Reviews|January 15, 2025
Initiation and sequencing of guideline-directed medical therapy for heart failure across the ejection fraction spectrumIzza Shahid, Muhammad Shahzeb Khan, Javed Butler, et al.
The American Journal of Medicine|July 8, 2024
Association Between SGLT2 Inhibitors and Risk of Dementia and Parkinson's Disease: A Meta-Analysis of 12 Randomized Controlled TrialsVikash Jaiswal, Yusra Mashkoor, Nishchita Raj, et al.
Pageof 161